Jonas Salk (乔纳斯·索尔克)
American virologist who developed the first safe inactivated polio vaccine. He declined to patent the vaccine and later founded the Salk Institute, dedicating his life to public health, biomedical research, and ethics in science.
- Birth
- 1914-10-28 08:00 · New York City
- Gender
- Male
- Time Source
- AI inferred
Birth Time Verification
Core Analysis
Traits
Research focus
As a Ding Fire Day Master supported by multiple Jia Wood Direct Resource stars, his chart emphasizes sustained learning and academic grounding, explaining his long-term dedication to vaccine research and careful experimentation.
Sense of social responsibility
The presence of both Officer stars and Resource stars highlights strong ethical boundaries and commitment to public service, reflected in his choice to prioritize public benefit over personal gain.
Innovation and execution
Output stars become active during key Luck Pillars, supporting bold experimentation and the ability to organize and carry out large-scale clinical trials.
Endurance under pressure
While strong Resource energy supports resilience, the draining effect of Water on Fire suggests that long-term pressure and sacrifice were recurring themes in his life.
Timeline
Each year shows the event, luck pillar, annual pillar, relations, and interpretation for direct comparison.
Early entry into a competitive academic environment
At age 13, Salk entered Townsend Harris High School, known for its intense academic competition, placing him early in a demanding educational setting.
Enrollment at City College of New York
After graduating early from Townsend Harris High School, Salk entered the City College of New York to continue his higher education.
Admission to New York University School of Medicine
After completing his undergraduate degree in chemistry, Salk entered NYU School of Medicine. Initially considering law, he shifted to medicine under his mother’s encouragement.
Medical degree and commitment to research
Salk earned his MD and chose to focus on medical research rather than clinical practice, laying the groundwork for his future in virology.
Joining vaccine research at the University of Michigan
Recommended by mentor Thomas Francis, Salk joined the University of Michigan School of Public Health to work on military-funded influenza vaccine research.
Controversial influenza vaccine trials
Salk conducted human influenza vaccine trials at a state psychiatric hospital, a bold and controversial step that marked a high-risk turning point in his career.
Appointment as professor and lab director
Salk was appointed professor at the University of Pittsburgh School of Medicine and given an independent laboratory to pursue polio research.
Launch of polio virus typing research
With support from the National Foundation for Infantile Paralysis, Salk began systematic research on polio virus strains and inactivation methods.
Breakthrough in animal trials
Salk’s team achieved key success in animal testing, confirming the safety and effectiveness of the inactivated polio vaccine.
Self-testing the vaccine
Salk tested the experimental vaccine on himself and his family, demonstrating confidence in its safety and clearing the way for large-scale trials.
Leading the largest public health trial
He led the largest double-blind public health trial in US history, involving over a million children, to test the polio vaccine.
Global recognition of vaccine success
The polio vaccine was officially declared safe and effective, earning national acclaim and enabling rapid mass immunization.
Global adoption of the polio vaccine
The vaccine was adopted in around 90 countries, dramatically reducing polio incidence worldwide and becoming a public health milestone.
Founding of the Salk Institute
Salk founded the Salk Institute in La Jolla, supported by major grants and attracting leading scientists, solidifying his standing in the scientific world.
Passing in La Jolla
Jonas Salk passed away in La Jolla, California, at age 80, leaving a profound scientific and humanitarian legacy.
FAQ
Why was he able to successfully develop the polio vaccine? +
Why did he give up the vaccine patent and personal profit? +
How does his career path relate to his BaZi? +
What made 1955 the key turning point? +
Is there BaZi support for his continued research later in life? +
Read Your BaZi
After reading a public case, you can also generate a BaZi report for yourself.